Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Pulmonary Arterial Hypertension.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00370214
What this trial is testing

REVEAL Registry™: Registry to Evaluate Early And Long-term PAH Disease Management

Who this might be right for
Pulmonary Hypertension
Actelion 3,515
Not applicableStudy completedNCT01781052
What this trial is testing

Observational Description of Compliance for the Daily Ventavis Use Via the Insight Program in Class III Pulmonary Arterial Hypertension Patients

Who this might be right for
Pulmonary Arterial Hypertension
Bayer 17
Early research (Phase 1)Study completedNCT04991181
What this trial is testing

Absorption, Distribution, Metabolism and Excretion of BIA 5-1058

Who this might be right for
Pulmonary Arterial Hypertension
Bial - Portela C S.A. 15
Not applicableStudy completedNCT02631421
What this trial is testing

Dysregulation of Lipid Metabolism and Right Ventricular Function in PAH

Who this might be right for
Pulmonary Arterial Hypertension
Vanderbilt University 15
Not applicableStudy completedNCT01043627
What this trial is testing

Sildenafil to Tadalafil in Pulmonary Arterial Hypertension (SITAR)

Who this might be right for
Pulmonary Arterial Hypertension
Mayo Clinic 100
Testing effectiveness (Phase 2)Study completedNCT02276872
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of Oral Treprostinil in Pediatric PAH Patients Aged 7 to 17 Years

Who this might be right for
PAH
United Therapeutics 32
Early research (Phase 1)WithdrawnNCT01880866
What this trial is testing

(-)-Epicatechin and Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
University of California, San Francisco
Not applicableEnded earlyNCT01835080
What this trial is testing

Obstructive Sleep Apnea (OSA) in Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial HypertensionObstructive Sleep Apnea
Inova Health Care Services 2
Large-scale testing (Phase 3)Study completedNCT01808313
What this trial is testing

Efficacy Study of Ambrisentan in Chinese Patients With Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Vascular Disease
GlaxoSmithKline 134
Early research (Phase 1)Study completedNCT05427162
What this trial is testing

Single and Multiple Doses of Different Formulations of a Prostacyclin Receptor Agonist

Who this might be right for
Pulmonary Arterial Hypertension
Actelion 88
Testing effectiveness (Phase 2)Ended earlyNCT02927366
What this trial is testing

Safety, Pharmacokinetics and Efficacy Study of QCC374 in PAH Patients

Who this might be right for
Pulmonary Arterial Hypertension
Novartis Pharmaceuticals 8
Testing effectiveness (Phase 2)Study completedNCT05224531
What this trial is testing

Effect of CS1 in Subjects With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Cereno Scientific AB 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT07073820
What this trial is testing

Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489

Who this might be right for
Pulmonary Hypertension
Pfizer 42
Large-scale testing (Phase 3)Active Not RecruitingNCT04691154
What this trial is testing

Evaluate the Safety and Tolerability of L606 in Subjects With PAH or PH-ILD

Who this might be right for
Pulmonary Arterial HypertensionPulmonary Hypertension Due to Lung Diseases
Liquidia Technologies, Inc. 28
Testing effectiveness (Phase 2)Study completedNCT04712669
What this trial is testing

Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension (Core OLE)

Who this might be right for
Pulmonary Arterial Hypertension
Altavant Sciences GmbH 108
Not applicableLooking for participantsNCT06605794
What this trial is testing

FreeFlow Percutaneous Atrial Septal Shunt for IPAH

Who this might be right for
Pulmonary Arterial Hypertension
Shanghai Zhongshan Hospital 30
Post-approval studies (Phase 4)Study completedNCT00058929
What this trial is testing

A Transition Study From Flolan® to Remodulin® in Patients With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial HypertensionPulmonary Hypertension
United Therapeutics 39
Large-scale testing (Phase 3)Ended earlyNCT00723554
What this trial is testing

Iloprost Power Disc-15 in Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Actelion 63
Testing effectiveness (Phase 2)Study completedNCT05179356
What this trial is testing

Dapagliflozin in Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial HypertensionChronic Thromboembolic Pulmonary Hypertension
Mads Ersbøll 52
Not applicableLooking for participantsNCT06865118
What this trial is testing

Home-Based Clinical Management of Cardiac Complications in Systemic Sclerosis

Who this might be right for
Systemic Sclerosis (SSc)Pulmonary Arterial Hypertension (PAH)Home Monitoring Follow-up
Oslo University Hospital 20
Next Page